Authors: KASPRZYK PG SULLIVAN TL HUNT JD GUBISH CT SCOPPA CA OELKUCT M BIRD R FISCHER PH SIEGFRIED JM KING CR

Citation: Pg. Kasprzyk et al., ACTIVITY OF ANTI-ERBB-2 RECOMBINANT TOXIN OLX-209 ON LUNG-CANCER CELL-LINES IN THE ABSENCE OF ERBB-2 GENE AMPLIFICATION, Clinical cancer research, 2(1), 1996, pp. 75-80

Authors: KING CR KASPRZYK PG FISCHER PH BIRD RE TURNER NA

Citation: Cr. King et al., PRECLINICAL TESTING OF AN ANTI-ERBB-2 RECOMBINANT TOXIN, Breast cancer research and treatment, 38(1), 1996, pp. 19-25

Authors: REITER Y BRINKMANN U JUNG SH LEE BK KASPRZYK PG KING CR PASTAN I

Citation: Y. Reiter et al., IMPROVED BINDING AND ANTITUMOR-ACTIVITY OF A RECOMBINANT ANTI-ERBB2 IMMUNOTOXIN BY DISULFIDE STABILIZATION OF THE FV FRAGMENT, The Journal of biological chemistry, 269(28), 1994, pp. 18327-18331

Authors: AVIS I JETT M KASPRZYK PG CUTTITTA F TRESTON AM MANECKJEE R MULSHINE JL

Citation: I. Avis et al., EFFECT OF GASTRIN-RELEASING PEPTIDE ON THE PANCREATIC TUMOR-CELL LINE(CAPAN), Molecular carcinogenesis, 8(4), 1993, pp. 214-220